In the News

A Start-Up Suggests a Fix to the Health Care Morass

Despite the drama in Washington, D.C. over the Affordable Care Act and its repeal or replacement, investors are still seeing a big future in the expansion of healthcare and the creation of Accountable Care Organizations (ACOs) in Medicare. Perhaps the most interesting and groundbreaking company created...

Swisslog Healthcare Invests in PipelineRx to Establish Strategic Partnership

Swisslog Healthcare has announced that it will be investing significantly in PipelineRx. The two companies will be using their new partnership to improve hospital workflow efficiency and to provide patients with a better experience. The two companies will be improving digitization options for their clients to...

Genomic Medicine Has Entered the Building

As the promises of genomics are starting to come to fruition, hospitals need to start preparing for the changes genomics will bring to health care. Thousands of Americans are being treated, or are changing their treatments, based on information from genome testing. The cost of whole...

Aledade to Create Physician-Led ACO in New Jersey

Bethesda, Maryland-based Aledade, a value-based care network with 15 accountable care organizations (ACOs), is planning to form a primary care physician-led ACO in New Jersey in January 2018. Aledade will collaborate with the New Jersey Academy of Family Physicians for the ACO. As part of the...

Healthcare is Looking to the Tech World for Recruitment

It's no surprise that the healthcare sector is full of executives with health-related backgrounds. A 2011 study of CEOs at the best hospitals in the US found that most CEOs specialized in cardiovascular care, cancer, and digestive disorders. And according to the Harvard Business Review,...

Amazon Sees GRAIL as a Special Opportunity for its Cloud Business

In March 2017, Amazon invested in GRAIL, a health startup that is researching deep sequencing technology to discover early signs of cancer in the blood. At the time, it was unclear as to why Amazon would be interested in a company like this, given the...

Alphabet Invests in Bay Area Biotech Startup, Builds It a New Lab on Verily Campus

Verily, Alphabet’s life sciences spinoff, has invested in Bay Area biotech startup Freenome in a $65 million Series A round. Freenome’s work revolves around detecting early-stage cancer. As part of the investment, Verily constructed a new lab for the company. Freenome’s 40 employees have already moved to...